The American College of Rheumatology (ACR) has established updated recommendations for the treatment of systemic lupus erythematosus (SLE). The overall goal of treatment is to control lupus [...]
Food and Drug Administration (FDA) has approved several therapies specifically for lupus nephritis (LN). These drugs have been studied in clinical trials and shown to help protect kidney function [...]
If you follow lupus research, you may have heard about CAR-T cell therapy—an innovative treatment approach currently being investigated for people with complicated, refractory systemic lupus [...]
A liquid biopsy for kidney lupus is being developed. It relies on determining levels of tenascin C in the urine. It’s a predictor of kidney function loss in lupus. – Dr. Robert Katz, LSI's Board [...]
According to new research (Law, et. All, Nature, 2024), it may be that T lymphocytes appear to play a more important role than we thought in causing active lupus. They […]
Recent lupus research has received significant coverage bringing encouraging results. The research was partially funded by the Lupus Research Alliance (LRA) – an organization the LSI [...]
By Irene Blanco, MD, MSProfessor of Medicine-Rheumatologyco-Director of the Clinical Research Ethics & Equity Consultative Service (CREEC) Lupus can have long-term consequences on patients’ [...]